A Population of Multipotent CD34-Positive Adipose Stromal Cells Share Pericyte and Mesenchymal Surface Markers, Reside in a Periendothelial Location, and Stabilize Endothelial Networks

By D. Traktuev, Stephanie Merfeld‐Clauss, Jingling Li, M. Kolonin, W. Arap, R. Pasqualini, B. Johnstone, K. March. Circulation Research, 2008

870 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

A perivascular origin for mesenchymal stem cells in multiple human organs. (2008, neutral): “…cells and MSCs. Interestingly, Schwab and Gargett (2007) have also suggested CD146 and PDGFRb as markers of MSC-like cells in the endometrium, and Traktuev et al. (2008) described multi- potent cells in WAT that coexpress some pericyte and MSC markers; that cell subset is, however, marked by…”
Pathophysiology of Acute Kidney Injury (2012, neutral): “MSC do not elicit immune responses, may be harvested from non bone marrow depots (such as adipose) and can be expanded in vitro making them potential useful therapeutically (82, 557).”
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity (2009, result): “Because earlier studies used broader gating to analyze macrophages in the stromal vascular fractio”
Mechanisms involved in the therapeutic properties of mesenchymal stem cells. (2009, background): “Short-term cultured MSCs from human adipose tissue, for example, express CD34 [13,14].”
Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal Cells (2012, neutral): “A proportion of ASCs express CD34 when freshly isolated, although the expression of CD34 gradually declines with successive passages [35,110,111,143,144]; it may not be entirely lost [144].”